Hinge Health, Inc. financial data

Symbol
HNGE on NYSE
Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity -838% % -31861%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 0 shares -100%
Entity Public Float $1,500,000,000 USD
Common Stock, Value, Issued $0 USD
Weighted Average Number of Shares Outstanding, Basic 78,858,000 shares 479%
Weighted Average Number of Shares Outstanding, Diluted 78,858,000 shares 376%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $154,211,000 USD 53%
Cost of Revenue $28,012,000 USD 31%
Research and Development Expense $31,921,000 USD 34%
Selling and Marketing Expense $63,520,000 USD 43%
General and Administrative Expense $36,851,000 USD 150%
Operating Income (Loss) $6,093,000 USD -58%
Nonoperating Income (Expense) $4,455,000 USD -16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,638,000 USD -213%
Income Tax Expense (Benefit) $206,000 USD -81%
Net Income (Loss) Attributable to Parent $528,261,000 USD -4327%
Earnings Per Share, Basic -0.02 USD/shares -300%
Earnings Per Share, Diluted -0.02 USD/shares -300%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $207,995,000 USD -31%
Marketable Securities, Current $218,685,000 USD
Accounts Receivable, after Allowance for Credit Loss, Current $66,061,000 USD 55%
Inventory, Net $15,636,000 USD 44%
Other Assets, Current $6,474,000 USD -6.8%
Assets, Current $533,904,000 USD -8.5%
Property, Plant and Equipment, Net $10,490,000 USD 42%
Operating Lease, Right-of-Use Asset $6,861,000 USD -29%
Intangible Assets, Net (Excluding Goodwill) $2,512,000 USD 39%
Goodwill $64,096,000 USD 4%
Other Assets, Noncurrent $13,726,000 USD 46%
Assets $744,761,000 USD 11%
Employee-related Liabilities, Current $9,259,000 USD 122%
Contract with Customer, Liability, Current $300,855,000 USD 38%
Liabilities, Current $362,409,000 USD 45%
Operating Lease, Liability, Noncurrent $3,816,000 USD -47%
Liabilities $366,225,000 USD 43%
Accumulated Other Comprehensive Income (Loss), Net of Tax $20,000 USD -129%
Retained Earnings (Accumulated Deficit) $1,050,996,000 USD -101%
Stockholders' Equity Attributable to Parent $178,662,000 USD
Liabilities and Equity $744,761,000 USD 11%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 0 shares -100%
Common Stock, Shares, Issued 0 shares -100%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $209,796,000 USD -31%
Deferred Tax Assets, Valuation Allowance $263,368,000 USD 79%
Deferred Tax Assets, Gross $265,998,000 USD 77%
Operating Lease, Liability $8,039,000 USD
Depreciation $300,000 USD -40%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,757,000 USD -392%
Lessee, Operating Lease, Liability, to be Paid $9,244,000 USD
Property, Plant and Equipment, Gross $30,270,000 USD 26%
Operating Lease, Liability, Current $4,223,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,546,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $4,802,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.0975 pure 15%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,205,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $310,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $90,283,000 USD 19%
Unrecognized Tax Benefits $10,209,000 USD 73%
Lessee, Operating Lease, Liability, to be Paid, Year Four $317,000 USD
Additional Paid in Capital $1,229,678,000 USD 1296%
Amortization of Intangible Assets $200,000 USD 100%
Deferred Tax Assets, Net of Valuation Allowance $1,005,000 USD -5%
Share-based Payment Arrangement, Expense $34,847,000 USD 30202%